Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Halozyme Therapeutics Total Assets 2010-2025 | HALO

Halozyme Therapeutics total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Halozyme Therapeutics total assets for the quarter ending March 31, 2025 were $2.197B, a 19.28% increase year-over-year.
  • Halozyme Therapeutics total assets for 2024 were $2.063B, a 19.05% increase from 2023.
  • Halozyme Therapeutics total assets for 2023 were $1.733B, a 5.88% decline from 2022.
  • Halozyme Therapeutics total assets for 2022 were $1.842B, a 66.74% increase from 2021.
  
Halozyme Therapeutics Annual Total Assets
(Millions of US $)
2024 $2,063
2023 $1,733
2022 $1,842
2021 $1,104
2020 $580
2019 $566
2018 $440
2017 $520
2016 $262
2015 $182
2014 $166
2013 $102
2012 $135
2011 $66
2010 $91
2009 $77
Halozyme Therapeutics Quarterly Total Assets
(Millions of US $)
2025-03-31 $2,197
2024-12-31 $2,063
2024-09-30 $2,118
2024-06-30 $1,969
2024-03-31 $1,842
2023-12-31 $1,733
2023-09-30 $1,893
2023-06-30 $1,810
2023-03-31 $1,699
2022-12-31 $1,842
2022-09-30 $1,865
2022-06-30 $1,781
2022-03-31 $1,162
2021-12-31 $1,104
2021-09-30 $1,185
2021-06-30 $1,026
2021-03-31 $967
2020-12-31 $580
2020-09-30 $524
2020-06-30 $527
2020-03-31 $492
2019-12-31 $566
2019-09-30 $370
2019-06-30 $418
2019-03-31 $429
2018-12-31 $440
2018-09-30 $445
2018-06-30 $475
2018-03-31 $495
2017-12-31 $520
2017-09-30 $357
2017-06-30 $345
2017-03-31 $227
2016-12-31 $262
2016-09-30 $282
2016-06-30 $296
2016-03-31 $309
2015-12-31 $182
2015-09-30 $159
2015-06-30 $174
2015-03-31 $159
2014-12-31 $166
2014-09-30 $165
2014-06-30 $182
2014-03-31 $198
2013-12-31 $102
2013-09-30 $110
2013-06-30 $107
2013-03-31 $117
2012-12-31 $135
2012-09-30 $108
2012-06-30 $122
2012-03-31 $135
2011-12-31 $66
2011-09-30 $78
2011-06-30 $90
2011-03-31 $81
2010-12-31 $91
2010-09-30 $100
2010-06-30 $51
2010-03-31 $65
2009-12-31 $77
2009-09-30 $86
2009-06-30 $96
2009-03-31 $69
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $6.506B $1.015B
Halozyme Therapeutics Inc. is a biopharmaceutical company, focused on the development and commercialization of novel treatments for oncology indications by targeting tumor microenvironment. The company's ENHANZE drug delivery technology helps in developing subcutaneous formulation of drugs. The company also licenses its novel drug delivery technology, ENHANZE. Several companies including Roche, Takeda, J&J, AbbVie, Lilly, Bristol-Myers and others are using this technology for developing subcutaneous formulation of their currently marketed drugs. It also recognizes revenues from sale of drug products to its collaboration partners for development of drugs using its ENHANZE platform. The company also has one approved product in its portfolio, Hylenex recombinant as an adjuvant to facilitate subcutaneous fluid administration. Although Halozyme has one marketed product, it derives the majority of its revenues from royalties on sales of partnered drugs.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $219.077B 16.35
Amgen (AMGN) United States $146.493B 13.12
Gilead Sciences (GILD) United States $132.093B 13.72
Vertex Pharmaceuticals (VRTX) United States $113.900B 0.00
Bristol Myers Squibb (BMY) United States $95.486B 6.39
GSK (GSK) United Kingdom $78.331B 9.38
CSL (CSLLY) Australia $75.915B 0.00
Regeneron Pharmaceuticals (REGN) United States $55.270B 13.41
Alnylam Pharmaceuticals (ALNY) United States $40.829B 0.00
Argenex SE (ARGX) Netherlands $33.019B 90.13
BioNTech SE (BNTX) Germany $24.763B 0.00
Insmed (INSM) United States $20.000B 0.00
Royalty Pharma (RPRX) United States $19.903B 8.41
Biogen (BIIB) United States $18.281B 7.89
Illumina (ILMN) United States $14.344B 27.21
Genmab (GNMSF) Denmark $13.948B 14.26
Genmab (GMAB) Denmark $13.260B 14.88
Incyte (INCY) United States $13.020B 98.91
Exelixis (EXEL) United States $11.827B 20.08
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $11.719B 0.00
Ascendis Pharma (ASND) Denmark $10.746B 0.00
QIAGEN (QGEN) Netherlands $10.383B 20.20
BioMarin Pharmaceutical (BMRN) United States $10.371B 16.85
Moderna (MRNA) United States $9.928B 0.00
Exact Sciences (EXAS) United States $9.911B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $9.633B 24.60
Blueprint Medicines (BPMC) United States $8.292B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.262B 0.00
Roivant Sciences (ROIV) United Kingdom $7.818B 0.00
Bio-Techne Corp (TECH) United States $7.729B 28.83
Revolution Medicines (RVMD) United States $7.458B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Repligen (RGEN) United States $6.748B 75.54
Jazz Pharmaceuticals (JAZZ) Ireland $6.460B 6.34
Legend Biotech (LEGN) United States $6.220B 0.00
Guardant Health (GH) United States $6.015B 0.00
TG Therapeutics (TGTX) United States $5.804B 152.33
Telix Pharmaceuticals (TLX) Australia $5.544B 0.00
Nuvalent (NUVL) United States $5.456B 0.00
Axsome Therapeutics (AXSM) United States $5.005B 0.00
Alkermes (ALKS) Ireland $4.825B 12.95
Akero Therapeutics (AKRO) United States $4.307B 0.00
Vaxcyte (PCVX) United States $4.289B 0.00
ADMA Biologics Inc (ADMA) United States $4.266B 31.91
Zealand Pharma (ZLDPF) Denmark $4.068B 0.00
Krystal Biotech (KRYS) United States $3.986B 30.72
Zai Lab (ZLAB) China $3.973B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.953B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.934B 0.00
PTC Therapeutics (PTCT) United States $3.931B 6.84
Cytokinetics (CYTK) United States $3.898B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.762B 33.06
Merus (MRUS) Netherlands $3.650B 0.00
SpringWorks Therapeutics (SWTX) United States $3.539B 0.00
Avidity Biosciences (RNA) United States $3.513B 0.00
Arcellx (ACLX) United States $3.506B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.482B 0.00
Protagonist Therapeutics (PTGX) United States $3.307B 71.15
Ascentage Pharma Group - (AAPG) China $3.236B 0.00
Scholar Rock Holding (SRRK) United States $3.160B 0.00
Metsera (MTSR) United States $3.047B 0.00
Kymera Therapeutics (KYMR) United States $3.014B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.872B 0.00
Viking Therapeutics (VKTX) United States $2.792B 0.00
Alvotech (ALVO) Luxembourg $2.753B 15.74
Anbio Biotechnology (NNNN) Germany $2.712B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.651B 0.00
Immunovant (IMVT) United States $2.644B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.490B 0.00
ImmunityBio (IBRX) United States $2.436B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.416B 0.00
Ligand Pharmaceuticals (LGND) United States $2.218B 0.00
Apellis Pharmaceuticals (APLS) United States $2.215B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.142B 0.00
Twist Bioscience (TWST) United States $2.117B 0.00
Vericel (VCEL) United States $2.104B 1393.33
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.096B 0.00
Bavarian Nordic (BVNRY) Denmark $2.049B 10.82
Denali Therapeutics (DNLI) United States $1.979B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.963B 0.00
Belite Bio (BLTE) United States $1.958B 0.00
CG Oncology (CGON) United States $1.956B 0.00
Agios Pharmaceuticals (AGIO) United States $1.931B 0.00
Apogee Therapeutics (APGE) United States $1.904B 0.00
IDEAYA Biosciences (IDYA) United States $1.876B 0.00
Sarepta Therapeutics (SRPT) United States $1.854B 0.00
NovoCure (NVCR) Jersey $1.852B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.834B 12.19
Disc Medicine (IRON) United States $1.790B 0.00
Amicus Therapeutics (FOLD) United States $1.758B 190.33
Arcutis Biotherapeutics (ARQT) United States $1.717B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.706B 0.00
Certara (CERT) United States $1.697B 31.70
Beam Therapeutics (BEAM) United States $1.680B 0.00
Adaptive Biotechnologies (ADPT) United States $1.604B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.563B 0.00
GRAIL (GRAL) United States $1.549B 0.00
Edgewise Therapeutics (EWTX) United States $1.492B 0.00
Biohaven (BHVN) United States $1.477B 0.00
89BIO (ETNB) United States $1.460B 0.00
ANI Pharmaceuticals (ANIP) United States $1.430B 14.74
Vera Therapeutics (VERA) United States $1.381B 0.00
Janux Therapeutics (JANX) United States $1.354B 0.00
Celldex Therapeutics (CLDX) United States $1.354B 0.00
Mesoblast (MESO) Australia $1.298B 0.00
Travere Therapeutics (TVTX) United States $1.287B 0.00
BGM Group (BGM) China $1.276B 0.00
Structure Therapeutics (GPCR) United States $1.267B 0.00
CureVac (CVAC) Germany $1.210B 5.86
Viridian Therapeutics (VRDN) United States $1.200B 0.00
Dynavax Technologies (DVAX) United States $1.173B 69.79
MannKind (MNKD) United States $1.153B 23.72
Pacira BioSciences (PCRX) United States $1.145B 10.90
Liquidia Technologies (LQDA) United States $1.134B 0.00
CorMedix Inc (CRMD) United States $1.123B 75.27
Niagen Bioscience (NAGE) United States $1.074B 151.56
WAVE Life Sciences (WVE) Singapore $1.073B 0.00
Novavax (NVAX) United States $1.022B 2.38
AbCellera Biologics (ABCL) Canada $0.994B 0.00
Intellia Therapeutics (NTLA) United States $0.956B 0.00
Arcus Biosciences (RCUS) United States $0.914B 0.00
Nurix Therapeutics (NRIX) United States $0.913B 0.00
Pharvaris (PHVS) Netherlands $0.911B 0.00
Geron (GERN) United States $0.904B 0.00
NeoGenomics (NEO) United States $0.902B 0.00
Mineralys Therapeutics (MLYS) United States $0.897B 0.00
Spyre Therapeutics (SYRE) United States $0.885B 0.00
MiMedx (MDXG) United States $0.877B 21.21
Zymeworks (ZYME) United States $0.868B 0.00
Oculis Holding AG (OCS) Switzerland $0.858B 0.00
LENZ Therapeutics (LENZ) United States $0.858B 0.00
Oric Pharmaceuticals (ORIC) United States $0.852B 0.00
Praxis Precision Medicines (PRAX) United States $0.848B 0.00
Cogent Biosciences (COGT) United States $0.827B 0.00
Anavex Life Sciences (AVXL) United States $0.794B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.791B 0.00
ArriVent BioPharma (AVBP) United States $0.780B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
UniQure (QURE) Netherlands $0.764B 0.00
Immunome (IMNM) United States $0.760B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.760B 0.00
Gyre Therapeutics (GYRE) United States $0.729B 194.25
Replimune (REPL) United States $0.712B 0.00
Pharming Group (PHAR) Netherlands $0.702B 0.00
Vir Biotechnology (VIR) United States $0.698B 0.00
Nuvation Bio (NUVB) United States $0.691B 0.00
Trevi Therapeutics (TRVI) United States $0.674B 0.00
AnaptysBio (ANAB) United States $0.670B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.661B 0.00
Urogen Pharma (URGN) United States $0.659B 0.00
Immatics (IMTX) Germany $0.659B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.657B 0.00
Arbutus Biopharma (ABUS) United States $0.653B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Stoke Therapeutics (STOK) United States $0.633B 14.67
Sionna Therapeutics (SION) United States $0.622B 0.00
Iovance Biotherapeutics (IOVA) United States $0.618B 0.00
GH Research (GHRS) Ireland $0.608B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.588B 0.00
Sana Biotechnology (SANA) United States $0.586B 0.00
Sage Therapeutics (SAGE) United States $0.582B 0.00
Upstream Bio (UPB) United States $0.577B 0.00
Tango Therapeutics (TNGX) United States $0.577B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.570B 0.00
Cidara Therapeutics (CDTX) United States $0.564B 0.00
Keros Therapeutics (KROS) United States $0.559B 0.00
Dianthus Therapeutics (DNTH) United States $0.553B 0.00
Castle Biosciences (CSTL) United States $0.544B 36.96
Arvinas (ARVN) United States $0.540B 0.00
Opthea (OPT) Australia $0.525B 0.00
Tyra Biosciences (TYRA) United States $0.516B 0.00
Kura Oncology (KURA) United States $0.508B 0.00
MeiraGTx Holdings (MGTX) United States $0.507B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.502B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.501B 0.00
Bicara Therapeutics (BCAX) United States $0.501B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.499B 0.00
Maze Therapeutics (MAZE) United States $0.470B 0.00
Septerna (SEPN) United States $0.469B 0.00
Fortrea Holdings (FTRE) United States $0.462B 12.75
Oxford BioMedica (OXBDF) United Kingdom $0.453B 0.00
Myriad Genetics (MYGN) United States $0.448B 0.00
Cullinan Therapeutics (CGEM) United States $0.447B 0.00
ATyr Pharma (ATYR) United States $0.443B 0.00
Precigen (PGEN) United States $0.437B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.436B 0.00
Celcuity (CELC) United States $0.434B 0.00
PureTech Health (PRTC) United States $0.420B 0.00
Kamada (KMDA) Israel $0.417B 25.03
Rapport Therapeutics (RAPP) United States $0.397B 0.00
Zenas BioPharma (ZBIO) United States $0.396B 0.00
Cytek Biosciences (CTKB) United States $0.395B 0.00
REGENXBIO (RGNX) United States $0.394B 0.00
Erasca (ERAS) United States $0.394B 0.00
Abivax SA (ABVX) France $0.388B 0.00
Fulcrum Therapeutics (FULC) United States $0.387B 0.00
ITeos Therapeutics (ITOS) United States $0.387B 0.00
Benitec Biopharma (BNTC) United States $0.382B 0.00
Northwest Biotherapeutics (NWBO) United States $0.375B 0.00
Vigil Neuroscience (VIGL) United States $0.371B 0.00
Eton Pharmaceuticals (ETON) United States $0.362B 0.00
Emergent Biosolutions (EBS) United States $0.354B 0.00
Absci (ABSI) United States $0.352B 0.00
Compass Therapeutics (CMPX) United States $0.351B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.350B 0.00
Tectonic Therapeutic (TECX) United States $0.350B 0.00
Solid Biosciences (SLDB) United States $0.350B 0.00
Rezolute (RZLT) United States $0.345B 0.00
Humacyte (HUMA) United States $0.343B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.339B 0.00
Prothena (PRTA) Ireland $0.326B 0.00
Inventiva S.A (IVA) France $0.325B 0.00
MBX Biosciences (MBX) United States $0.325B 0.00
Terns Pharmaceuticals (TERN) United States $0.321B 0.00
Astria Therapeutics (ATXS) United States $0.317B 0.00
XOMA Royalty (XOMA) United States $0.314B 0.00
Gossamer Bio (GOSS) United States $0.311B 0.00
Aura Biosciences (AURA) United States $0.309B 0.00
Abeona Therapeutics (ABEO) United States $0.297B 0.00
Aardvark Therapeutics (AARD) United States $0.289B 0.00
Olema Pharmaceuticals (OLMA) United States $0.287B 0.00
Ocugen (OCGN) United States $0.287B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.285B 58.00
Atea Pharmaceuticals (AVIR) United States $0.284B 0.00
Prime Medicine (PRME) United States $0.284B 0.00
Alpha Teknova (TKNO) United States $0.282B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.281B 0.00
Lifecore Biomedical (LFCR) United States $0.274B 0.00
Foghorn Therapeutics (FHTX) United States $0.273B 0.00
Entrada Therapeutics (TRDA) United States $0.267B 8.69
Allogene Therapeutics (ALLO) United States $0.267B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.266B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.265B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.263B 0.00
Annexon (ANNX) United States $0.261B 0.00
Amarin (AMRN) Ireland $0.261B 0.00
Inozyme Pharma (INZY) United States $0.258B 0.00
Sagimet Biosciences (SGMT) United States $0.256B 0.00
Cartesian Therapeutics (RNAC) United States $0.255B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.254B 0.00
Verastem (VSTM) United States $0.254B 0.00
Palvella Therapeutics (PVLA) United States $0.249B 0.00
Neurogene (NGNE) United States $0.246B 0.00
Third Harmonic Bio (THRD) United States $0.245B 0.00
Tvardi Therapeutics (TVRD) United States $0.238B 0.00
DBV Technologies S.A (DBVT) France $0.234B 0.00
Candel Therapeutics (CADL) United States $0.234B 0.00
MaxCyte (MXCT) United States $0.231B 0.00
BioStem Technologies (BSEM) $0.225B 9.15
Adherex Technologies (FENC) United States $0.223B 0.00
Prima BioMed (IMMP) Australia $0.222B 0.00
Design Therapeutics (DSGN) United States $0.221B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.214B 0.00
Adocia (ADOCY) France $0.213B 0.00
Semper Paratus Acquisition (TVGN) United States $0.213B 0.00
Inhibrx Biosciences (INBX) United States $0.211B 0.12
Cardiff Oncology (CRDF) United States $0.210B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.205B 0.00
ScPharmaceuticals (SCPH) United States $0.202B 0.00
I-Mab (IMAB) United States $0.201B 0.00
Instil Bio (TIL) United States $0.196B 0.00
Codexis (CDXS) United States $0.196B 0.00
Monopar Therapeutics (MNPR) United States $0.195B 0.00
Kodiak Sciences (KOD) United States $0.192B 0.00
Bright Minds Biosciences (DRUG) United States $0.191B 0.00
GENFIT S.A (GNFT) France $0.190B 0.00
CARGO Therapeutics (CRGX) United States $0.190B 0.00
AC Immune (ACIU) Switzerland $0.184B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.181B 0.00
Citius Oncology (CTOR) United States $0.179B 0.00
Editas Medicine (EDIT) United States $0.176B 0.00
CytomX Therapeutics (CTMX) United States $0.174B 4.50
Ventyx Biosciences (VTYX) United States $0.171B 0.00
SELLAS Life Sciences (SLS) United States $0.171B 0.00
Nuvectis Pharma (NVCT) United States $0.166B 0.00
Puma Biotechnology (PBYI) United States $0.166B 4.35
Innate Pharma S.A (IPHA) France $0.166B 0.00
Spero Therapeutics (SPRO) United States $0.164B 0.00
Voyager Therapeutics (VYGR) United States $0.163B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.157B 0.00
Anika Therapeutics (ANIK) United States $0.157B 0.00
DiaMedica Therapeutics (DMAC) United States $0.157B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.156B 0.00
BioAge Labs (BIOA) United States $0.156B 0.00
EnGene Holdings (ENGN) Canada $0.154B 0.00
Alumis (ALMS) United States $0.152B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.152B 0.00
Compugen (CGEN) Israel $0.145B 0.00
Molecular Partners AG (MOLN) Switzerland $0.145B 0.00
Alpha Cognition (ACOG) Canada $0.144B 0.00
INmune Bio (INMB) United States $0.143B 0.00
Kyverna Therapeutics (KYTX) United States $0.139B 0.00
Actuate Therapeutics (ACTU) United States $0.138B 0.00
Alector (ALEC) United States $0.137B 0.00
Agenus (AGEN) United States $0.132B 0.00
Fate Therapeutics (FATE) United States $0.131B 0.00
Black Diamond Therapeutics (BDTX) United States $0.129B 37.83
Elicio Therapeutics (ELTX) United States $0.128B 0.00
Nkarta (NKTX) United States $0.124B 0.00
Rapt Therapeutics (RAPT) United States $0.123B 0.00
Caribou Biosciences (CRBU) United States $0.123B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.122B 0.00
Neumora Therapeutics (NMRA) United States $0.121B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.119B 0.00
Greenwich LifeSciences (GLSI) United States $0.117B 0.00
23andMe Holding (MEHCQ) United States $0.117B 0.00
Seer (SEER) United States $0.116B 0.00
Theratechnologies (THTX) Canada $0.113B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.112B 0.00
BioHarvest Sciences (BHST) Canada $0.112B 0.00
TuHURA Biosciences (HURA) United States $0.111B 0.00
BeyondSpring (BYSI) United States $0.110B 0.00
Contineum Therapeutics (CTNM) United States $0.107B 0.00
Genelux (GNLX) United States $0.105B 0.00
C4 Therapeutics (CCCC) United States $0.104B 0.00
Sangamo Therapeutics (SGMO) United States $0.101B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.099B 0.00
Coya Therapeutics (COYA) United States $0.097B 0.00
HilleVax (HLVX) United States $0.094B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.094B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.094B 0.00
Whitehawk Therapeutics (WHWK) United States $0.092B 0.00
Tenaya Therapeutics (TNYA) United States $0.091B 0.00
Adagene (ADAG) China $0.090B 0.00
Entera Bio (ENTX) Israel $0.089B 0.00
Skye Bioscience (SKYE) United States $0.089B 0.00
Cabaletta Bio (CABA) United States $0.089B 0.00
EXoZymes (EXOZ) United States $0.088B 0.00
Immuneering (IMRX) United States $0.088B 0.00
Nautilus Biotechnology (NAUT) United States $0.088B 0.00
IO Biotech (IOBT) Denmark $0.086B 0.00
Coherus Oncology (CHRS) United States $0.084B 0.00
Invivyd (IVVD) United States $0.084B 0.00
Forte Biosciences (FBRX) United States $0.084B 0.00
TScan Therapeutics (TCRX) United States $0.082B 0.00
Climb Bio (CLYM) United States $0.081B 0.00
Cellectis S.A (CLLS) France $0.080B 0.00
XBiotech (XBIT) United States $0.079B 0.00
Jasper Therapeutics (JSPR) United States $0.077B 0.00
Pliant Therapeutics (PLRX) United States $0.077B 0.00
Zura Bio (ZURA) United States $0.077B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.075B 0.00
OKYO Pharma (OKYO) $0.074B 0.00
Elutia (ELUT) United States $0.072B 0.00
Inovio Pharmaceuticals (INO) United States $0.071B 0.00
PDS Biotechnology (PDSB) United States $0.070B 0.00
IGM Biosciences (IGMS) United States $0.069B 0.00
TELA Bio (TELA) United States $0.068B 0.00
Immunic (IMUX) United States $0.068B 0.00
Sutro Biopharma (STRO) United States $0.067B 0.00
Quantum Biopharma (QNTM) Canada $0.067B 0.00
Seres Therapeutics (MCRB) United States $0.065B 0.00
Alto Neuroscience (ANRO) United States $0.065B 0.00
Ikena Oncology (IKNA) United States $0.065B 0.00
Akoya Biosciences (AKYA) United States $0.064B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.064B 0.00
MediciNova (MNOV) United States $0.064B 0.00
Clearside Biomedical (CLSD) United States $0.064B 0.00
Biomea Fusion (BMEA) United States $0.064B 0.00
Renovaro (RENB) United States $0.063B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.062B 0.00
Immix Biopharma (IMMX) United States $0.062B 0.00
Repare Therapeutics (RPTX) Canada $0.060B 0.00
Oncolytics Biotech (ONCY) Canada $0.060B 0.00
Quince Therapeutics (QNCX) United States $0.060B 0.00
VistaGen Therapeutics (VTGN) United States $0.057B 0.00
CervoMed (CRVO) United States $0.057B 0.00
Oncobiologics (OTLK) United States $0.056B 0.00
Werewolf Therapeutics (HOWL) United States $0.056B 0.00
Genenta Science S.p.A (GNTA) Italy $0.056B 0.00
ZIVO Bioscience (ZIVO) United States $0.054B 0.00
Connect Biopharma Holdings (CNTB) United States $0.054B 0.00
Opus Genetics (IRD) United States $0.054B 0.00
InflaRx (IFRX) Germany $0.053B 0.00
Adicet Bio (ACET) United States $0.053B 0.00
Senti Biosciences (SNTI) United States $0.052B 0.00
Adlai Nortye (ANL) Cayman Islands $0.052B 0.00
RenovoRx (RNXT) United States $0.052B 0.00
Annovis Bio (ANVS) United States $0.051B 0.00
Fortress Biotech (FBIO) United States $0.051B 0.00
Precision BioSciences (DTIL) United States $0.050B 0.00
Cue Biopharma (CUE) United States $0.049B 0.00
VTv Therapeutics (VTVT) United States $0.048B 0.00
Shattuck Labs (STTK) United States $0.048B 0.00
Celularity (CELU) United States $0.048B 0.00
Atara Biotherapeutics (ATRA) United States $0.047B 0.00
Adverum Biotechnologies (ADVM) United States $0.047B 0.00
PepGen (PEPG) United States $0.045B 0.00
Kalaris Therapeutics (KLRS) United States $0.044B 0.00
Aligos Therapeutics (ALGS) United States $0.044B 0.00
Applied Therapeutics (APLT) United States $0.042B 0.00
Mersana Therapeutics (MRSN) United States $0.042B 0.00
Exicure (XCUR) United States $0.041B 0.00
Artiva Biotherapeutics (ARTV) United States $0.039B 0.00
Alterity Therapeutics - (ATHE) Australia $0.039B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.037B 0.00
Clene (CLNN) United States $0.037B 0.00
Vor Biopharma (VOR) $0.036B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.036B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.035B 0.00
Xilio Therapeutics (XLO) United States $0.035B 0.00
Scilex Holding (SCLX) United States $0.035B 0.00
Radiopharm Theranostics - (RADX) Australia $0.035B 0.00
Pluri (PLUR) Israel $0.034B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.034B 0.00
ABVC BioPharma (ABVC) United States $0.033B 0.00
Estrella Immunopharma (ESLA) United States $0.033B 0.00
Rein Therapeutics (RNTX) United States $0.033B 0.00
Lantern Pharma (LTRN) United States $0.033B 0.00
OnKure Therapeutics (OKUR) United States $0.033B 0.00
AN2 Therapeutics (ANTX) United States $0.032B 0.00
Medicus Pharma (MDCX) United States $0.032B 0.00
CAMP4 Therapeutics (CAMP) United States $0.032B 0.00
Kezar Life Sciences (KZR) United States $0.031B 0.00
MiNK Therapeutics (INKT) United States $0.030B 0.00
Grace Therapeutics (GRCE) Canada $0.030B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.029B 0.00
Dyadic (DYAI) United States $0.028B 0.00
Rani Therapeutics Holdings (RANI) United States $0.028B 0.00
FibroBiologics (FBLG) United States $0.028B 0.00
KALA BIO (KALA) United States $0.026B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.025B 0.00
ALX Oncology Holdings (ALXO) United States $0.025B 0.00
Generation Bio (GBIO) United States $0.024B 0.00
BioAtla (BCAB) United States $0.024B 0.00
Tenax Therapeutics (TENX) United States $0.023B 0.00
Boundless Bio (BOLD) United States $0.023B 0.00
Femasys (FEMY) United States $0.023B 0.00
Elevation Oncology (ELEV) United States $0.023B 0.00
Dare Bioscience (DARE) United States $0.023B 0.00
Cadrenal Therapeutics (CVKD) United States $0.023B 0.00
Curis (CRIS) United States $0.022B 0.00
Chemomab Therapeutics (CMMB) Israel $0.022B 0.00
CalciMedica (CALC) United States $0.022B 0.00
Passage Bio (PASG) United States $0.021B 0.00
Ovid Therapeutics (OVID) United States $0.021B 0.00
Lisata Therapeutics (LSTA) United States $0.021B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.020B 0.00
BRIACELL THERAP (BCTX) Canada $0.020B 0.00
Q32 Bio (QTTB) United States $0.019B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.018B 0.00
Aytu BioPharma (AYTU) United States $0.018B 0.00
Longeveron (LGVN) United States $0.017B 0.00
Cingulate (CING) United States $0.017B 0.00
Lexaria Bioscience (LEXX) Canada $0.017B 0.00
Beyond Air (XAIR) United States $0.016B 0.00
SAB Biotherapeutics (SABS) United States $0.016B 0.00
Hoth Therapeutics (HOTH) United States $0.016B 0.00
Imunon (IMNN) United States $0.016B 0.00
Cognition Therapeutics (CGTX) United States $0.016B 0.00
Eyenovia (EYEN) United States $0.016B 0.00
Advanced Biomed (ADVB) United States $0.016B 0.00
HOOKIPA Pharma (HOOK) United States $0.015B 0.00
Promis Neurosciences (PMN) Canada $0.015B 0.00
Gelteq (GELS) Australia $0.015B 0.00
Abpro Holdings (ABP) United States $0.014B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
X4 Pharmaceuticals (XFOR) United States $0.014B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.014B 0.00
Synlogic (SYBX) United States $0.014B 0.00
Allarity Therapeutics (ALLR) United States $0.014B 0.00
GeoVax Labs (GOVX) United States $0.013B 0.00
NextCure (NXTC) United States $0.013B 0.00
MetaVia (MTVA) United States $0.013B 0.00
Rallybio (RLYB) United States $0.013B 0.00
UNITY Biotechnology (UBX) United States $0.013B 0.00
Leap Therapeutics (LPTX) United States $0.013B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
IBio (IBIO) United States $0.012B 0.00
Athira Pharma (ATHA) United States $0.012B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.011B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
Bolt Biotherapeutics (BOLT) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Equillium (EQ) United States $0.010B 0.00
Sensei Biotherapeutics (SNSE) United States $0.010B 0.00
BioXcel Therapeutics (BTAI) United States $0.010B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
LakeShore Biopharma (LSB) China $0.009B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
Turnstone Biologics (TSBX) United States $0.009B 0.00
GT Biopharma (GTBP) United States $0.008B 0.00
Jade Biosciences (JBIO) United States $0.008B 0.00
Intensity Therapeutics (INTS) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.007B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
Novogen (KZIA) Australia $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
HCW Biologics (HCWB) United States $0.007B 0.00
BioAffinity Technologies (BIAF) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.006B 0.00
GENPREX (GNPX) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Apollomics (APLM) United States $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
Soligenix (SNGX) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
180 Life Sciences (ATNF) United States $0.005B 0.00
Mainz Biomed (MYNZ) Germany $0.005B 0.00
Mustang Bio (MBIO) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
Moleculin Biotech (MBRX) United States $0.004B 0.00
VivoSim Labs (VIVS) United States $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Adial Pharmaceuticals (ADIL) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Alzamend Neuro (ALZN) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
NuCana (NCNA) United Kingdom $0.001B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00